Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Blood Pressure Disorders Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
BioRestorative Therapies Inc
Capricor Therapeutics Inc
Arena Pharmaceuticals Inc
Boryung Pharmaceutical Co Ltd
Camurus AB
Aerogen Ltd
Ascendia Pharmaceuticals LLC
Chong Kun Dang Pharmaceutical Corp
Biolab Farmaceutica Ltda
Complexa Inc
Celsion Corp
Corion Biotech Srl
Ascendis Pharma A/S
AnGes Inc
Bayer AG
Ache Laboratorios Farmaceuticos SA
Acceleron Pharma Inc
Chiesi Farmaceutici SpA
Bristol-Myers Squibb Co
Chugai Pharmaceutical Co Ltd
Bioblue Technologies Inc
CJ HealthCare Corp
A1M Pharma AB
Biogen Inc
Celtaxsys Inc
Bial - Portela & Ca SA
By Type:
Angiotensin Receptor Blockers (ARBs)
Others
Angiotensin Converting Enzyme (ACE) Inhibitors
Diuretics
By Application:
Hypertension
Hypotension
Pulmonary Hypertension
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Blood Pressure Disorders Drug Market Overview 2018-2029
-
1.1 China Blood Pressure Disorders Drug Industry Development Overview
-
1.2 China Blood Pressure Disorders Drug Industry Development History
-
1.3 China Blood Pressure Disorders Drug Industry Market Size (2018-2029)
-
1.4 China Blood Pressure Disorders Drug Market Analysis by Type from Production Side
-
1.4.1 China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2029)
-
1.4.2 China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2029)
-
1.4.4 China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)
-
1.5 China Blood Pressure Disorders Drug Market Analysis by Application from Consumption End
-
1.5.1 China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Hypertension (2018-2029)
-
1.5.2 China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Hypotension (2018-2029)
-
1.5.3 China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Pulmonary Hypertension (2018-2029)
-
1.6 China Blood Pressure Disorders Drug Market Analysis by Region
-
1.6.1 North China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Blood Pressure Disorders Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Blood Pressure Disorders Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Blood Pressure Disorders Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Blood Pressure Disorders Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Blood Pressure Disorders Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Blood Pressure Disorders Drug Industry Development
Chapter 3 Blood Pressure Disorders DrugIndustry Chain Analysis
-
3.1 Blood Pressure Disorders Drug Industry Chain
-
3.2 Blood Pressure Disorders Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Blood Pressure Disorders Drug Market
-
3.3 Blood Pressure Disorders Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Blood Pressure Disorders Drug Market
Chapter 4 China Blood Pressure Disorders Drug Market, by Type
-
4.1 China Blood Pressure Disorders Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Blood Pressure Disorders Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Blood Pressure Disorders Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Blood Pressure Disorders Drug Production Volume and Growth Rate of Angiotensin Receptor Blockers (ARBs)
-
4.5.2 China Blood Pressure Disorders Drug Production Volume and Growth Rate of Others
-
4.5.3 China Blood Pressure Disorders Drug Production Volume and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors
-
4.5.4 China Blood Pressure Disorders Drug Production Volume and Growth Rate of Diuretics
Chapter 5 China Blood Pressure Disorders Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Blood Pressure Disorders Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Blood Pressure Disorders Drug Market Size and Growth Rate, by Application
-
5.5.1 China Blood Pressure Disorders Drug Market Size and Growth Rate of Hypertension
-
5.5.2 China Blood Pressure Disorders Drug Market Size and Growth Rate of Hypotension
-
5.5.3 China Blood Pressure Disorders Drug Market Size and Growth Rate of Pulmonary Hypertension
Chapter 6 China Blood Pressure Disorders Drug Market, by Region
-
6.1 China Blood Pressure Disorders Drug Production Volume and Production Value, by Region
-
6.2 China Blood Pressure Disorders Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Blood Pressure Disorders Drug Market Analysis
-
7.1 North China Blood Pressure Disorders Drug Market, by Type
-
7.2 North China Blood Pressure Disorders Drug Market, by Application
Chapter 8 Central China Blood Pressure Disorders Drug Market Analysis
-
8.1 Central China Blood Pressure Disorders Drug Market, by Type
-
8.2 Central China Blood Pressure Disorders Drug Market, by Application
Chapter 9 South China Blood Pressure Disorders Drug Market Analysis
-
9.1 South China Blood Pressure Disorders Drug Market, by Type
-
9.2 South China Blood Pressure Disorders Drug Market, by Application
Chapter 10 East China Blood Pressure Disorders Drug Market Analysis
-
10.1 East China Blood Pressure Disorders Drug Market, by Type
-
10.2 East China Blood Pressure Disorders Drug Market, by Application
Chapter 11 Northeast China Blood Pressure Disorders Drug Market Analysis
-
11.1 Northeast China Blood Pressure Disorders Drug Market, by Type
-
11.2 Northeast China Blood Pressure Disorders Drug Market, by Application
Chapter 12 Southwest China Blood Pressure Disorders Drug Market Analysis
-
12.1 Southwest China Blood Pressure Disorders Drug Market, by Type
-
12.2 Southwest China Blood Pressure Disorders Drug Market, by Application
Chapter 13 Northwest China Blood Pressure Disorders Drug Market Analysis
-
13.1 Northwest China Blood Pressure Disorders Drug Market, by Type
-
13.2 Northwest China Blood Pressure Disorders Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 BioRestorative Therapies Inc
-
14.1.1 BioRestorative Therapies Inc Company Profile
-
14.1.2 BioRestorative Therapies Inc Blood Pressure Disorders Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Capricor Therapeutics Inc
-
14.2.1 Capricor Therapeutics Inc Company Profile
-
14.2.2 Capricor Therapeutics Inc Blood Pressure Disorders Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Arena Pharmaceuticals Inc
-
14.3.1 Arena Pharmaceuticals Inc Company Profile
-
14.3.2 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Boryung Pharmaceutical Co Ltd
-
14.4.1 Boryung Pharmaceutical Co Ltd Company Profile
-
14.4.2 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Camurus AB
-
14.5.1 Camurus AB Company Profile
-
14.5.2 Camurus AB Blood Pressure Disorders Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Aerogen Ltd
-
14.6.1 Aerogen Ltd Company Profile
-
14.6.2 Aerogen Ltd Blood Pressure Disorders Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Ascendia Pharmaceuticals LLC
-
14.7.1 Ascendia Pharmaceuticals LLC Company Profile
-
14.7.2 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Chong Kun Dang Pharmaceutical Corp
-
14.8.1 Chong Kun Dang Pharmaceutical Corp Company Profile
-
14.8.2 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Biolab Farmaceutica Ltda
-
14.9.1 Biolab Farmaceutica Ltda Company Profile
-
14.9.2 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Complexa Inc
-
14.10.1 Complexa Inc Company Profile
-
14.10.2 Complexa Inc Blood Pressure Disorders Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Celsion Corp
-
14.11.1 Celsion Corp Company Profile
-
14.11.2 Celsion Corp Blood Pressure Disorders Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Corion Biotech Srl
-
14.12.1 Corion Biotech Srl Company Profile
-
14.12.2 Corion Biotech Srl Blood Pressure Disorders Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Ascendis Pharma A/S
-
14.13.1 Ascendis Pharma A/S Company Profile
-
14.13.2 Ascendis Pharma A/S Blood Pressure Disorders Drug Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 AnGes Inc
-
14.14.1 AnGes Inc Company Profile
-
14.14.2 AnGes Inc Blood Pressure Disorders Drug Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Bayer AG
-
14.15.1 Bayer AG Company Profile
-
14.15.2 Bayer AG Blood Pressure Disorders Drug Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Ache Laboratorios Farmaceuticos SA
-
14.16.1 Ache Laboratorios Farmaceuticos SA Company Profile
-
14.16.2 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Acceleron Pharma Inc
-
14.17.1 Acceleron Pharma Inc Company Profile
-
14.17.2 Acceleron Pharma Inc Blood Pressure Disorders Drug Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Chiesi Farmaceutici SpA
-
14.18.1 Chiesi Farmaceutici SpA Company Profile
-
14.18.2 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 Bristol-Myers Squibb Co
-
14.19.1 Bristol-Myers Squibb Co Company Profile
-
14.19.2 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Chugai Pharmaceutical Co Ltd
-
14.20.1 Chugai Pharmaceutical Co Ltd Company Profile
-
14.20.2 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Market Performance
-
14.20.3 Product&Service Introduction
-
14.21 Bioblue Technologies Inc
-
14.21.1 Bioblue Technologies Inc Company Profile
-
14.21.2 Bioblue Technologies Inc Blood Pressure Disorders Drug Market Performance
-
14.21.3 Product&Service Introduction
-
14.22 CJ HealthCare Corp
-
14.22.1 CJ HealthCare Corp Company Profile
-
14.22.2 CJ HealthCare Corp Blood Pressure Disorders Drug Market Performance
-
14.22.3 Product&Service Introduction
-
14.23 A1M Pharma AB
-
14.23.1 A1M Pharma AB Company Profile
-
14.23.2 A1M Pharma AB Blood Pressure Disorders Drug Market Performance
-
14.23.3 Product&Service Introduction
-
14.24 Biogen Inc
-
14.24.1 Biogen Inc Company Profile
-
14.24.2 Biogen Inc Blood Pressure Disorders Drug Market Performance
-
14.24.3 Product&Service Introduction
-
14.25 Celtaxsys Inc
-
14.25.1 Celtaxsys Inc Company Profile
-
14.25.2 Celtaxsys Inc Blood Pressure Disorders Drug Market Performance
-
14.25.3 Product&Service Introduction
-
14.26 Bial - Portela & Ca SA
-
14.26.1 Bial - Portela & Ca SA Company Profile
-
14.26.2 Bial - Portela & Ca SA Blood Pressure Disorders Drug Market Performance
-
14.26.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Blood Pressure Disorders Drug Industry Research Conclusions
-
15.2 Blood Pressure Disorders Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Blood Pressure Disorders Drug Industry Market Size (2018-2029)
-
Figure China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2029)
-
Figure China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2029)
-
Figure China Blood Pressure Disorders Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)
-
Figure China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Hypertension (2018-2029)
-
Figure China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Hypotension (2018-2029)
-
Figure China Blood Pressure Disorders Drug Sales Volume, Sales Value and Growth Rate of Pulmonary Hypertension (2018-2029)
-
Figure North China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Blood Pressure Disorders Drug Market Size and Growth Rate from 2018-2029
-
Figure Blood Pressure Disorders Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Blood Pressure Disorders Drug Market Share by Type in 2018
-
Figure China Blood Pressure Disorders Drug Market Share by Type in 2023
-
Figure China Blood Pressure Disorders Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Volume and Growth Rate of Angiotensin Receptor Blockers (ARBs) (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Volume and Growth Rate of Angiotensin Converting Enzyme (ACE) Inhibitors (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Volume and Growth Rate of Diuretics (2018-2023)
-
Figure China Blood Pressure Disorders Drug Market Share by Application in 2018
-
Figure China Blood Pressure Disorders Drug Market Share by Application in 2023
-
Figure China Blood Pressure Disorders Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Blood Pressure Disorders Drug Market Size and Growth Rate of Hypertension (2018-2023)
-
Figure China Blood Pressure Disorders Drug Market Size and Growth Rate of Hypotension (2018-2023)
-
Figure China Blood Pressure Disorders Drug Market Size and Growth Rate of Pulmonary Hypertension (2018-2023)
-
Table China Blood Pressure Disorders Drug Production Volume by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Production Volume Share by Region (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Volume Share by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Production Value by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Production Value Share by Region (2018-2023)
-
Figure China Blood Pressure Disorders Drug Production Value Share by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Sales Volume by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Sales Volume Share by Region (2018-2023)
-
Figure China Blood Pressure Disorders Drug Sales Volume Share by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Sales Value by Region (2018-2023)
-
Table China Blood Pressure Disorders Drug Sales Value Share by Region (2018-2023)
-
Figure China Blood Pressure Disorders Drug Sales Value Share by Region (2018-2023)
-
Table North China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table North China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure North China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table North China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table North China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table Central China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table Central China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table Central China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table South China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table South China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure South China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table South China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table South China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table East China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table East China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure East China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table East China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table East China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table Northeast China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table Southwest China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Blood Pressure Disorders Drug Production Volume by Type (2018-2023)
-
Table Northwest China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Blood Pressure Disorders Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Blood Pressure Disorders Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Blood Pressure Disorders Drug Sales Volume Share by Application (2018-2023)
-
Table BioRestorative Therapies Inc Company Profile
-
Table BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Capricor Therapeutics Inc Company Profile
-
Table Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Arena Pharmaceuticals Inc Company Profile
-
Table Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Boryung Pharmaceutical Co Ltd Company Profile
-
Table Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Camurus AB Company Profile
-
Table Camurus AB Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Aerogen Ltd Company Profile
-
Table Aerogen Ltd Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Ascendia Pharmaceuticals LLC Company Profile
-
Table Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Chong Kun Dang Pharmaceutical Corp Company Profile
-
Table Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Biolab Farmaceutica Ltda Company Profile
-
Table Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Complexa Inc Company Profile
-
Table Complexa Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Celsion Corp Company Profile
-
Table Celsion Corp Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Corion Biotech Srl Company Profile
-
Table Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Ascendis Pharma A/S Company Profile
-
Table Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table AnGes Inc Company Profile
-
Table AnGes Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Ache Laboratorios Farmaceuticos SA Company Profile
-
Table Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Acceleron Pharma Inc Company Profile
-
Table Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Chiesi Farmaceutici SpA Company Profile
-
Table Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Co Company Profile
-
Table Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Chugai Pharmaceutical Co Ltd Company Profile
-
Table Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Bioblue Technologies Inc Company Profile
-
Table Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table CJ HealthCare Corp Company Profile
-
Table CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table A1M Pharma AB Company Profile
-
Table A1M Pharma AB Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Biogen Inc Company Profile
-
Table Biogen Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Celtaxsys Inc Company Profile
-
Table Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
Table Bial - Portela & Ca SA Company Profile
-
Table Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue, Price and Gross (2018-2023)
-
